Buckingham Capital Management, Inc. Merck & Co., Inc. Transaction History

Buckingham Capital Management, Inc.

$863 Million
Q3 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 14,727 shares of MRK stock, worth $1.46 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

14,727

Previous 14,767 0.27%

Holding current value

$1.46 Million

Previous $1.83 Million 8.53%

% of portfolio

0.19%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$111.15 - $128.97 $4,446 - $5,158	-40 Reduced 0.27%	14,727 $1.67 Million
Q2 2024 Jul 15, 2024	BUY	$123.8 - $132.96 $11,142 - $11,966	90 Added 0.61%	14,767 $1.83 Million
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $194,999 - $227,217	1,722 Added 13.29%	14,677 $1.94 Million
Q4 2023 Feb 07, 2024	BUY	$100.18 - $109.02 $102,183 - $111,200	1,020 Added 8.55%	12,955 $1.41 Million
Q3 2023 Oct 13, 2023	SELL	$102.95 - $114.33 $8,853 - $9,832	-86 Reduced 0.72%	11,935 $1.23 Million
Q2 2023 Jul 11, 2023	BUY	$108.61 - $118.38 $37,253 - $40,604	343 Added 2.94%	12,021 $1.39 Million
Q1 2023 Apr 11, 2023	BUY	$102.94 - $114.86 $87,499 - $97,631	850 Added 7.85%	11,678 $1.24 Million
Q4 2022 Jan 24, 2023	SELL	$87.44 - $112.11 $141,040 - $180,833	-1,613 Reduced 12.97%	10,828 $0
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $406,589 - $456,757	-4,810 Reduced 27.88%	12,441 $1.07 Million
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $361,344 - $409,601	-4,328 Reduced 20.06%	17,251 $1.57 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $607,339 - $680,788	-8,262 Reduced 27.69%	21,579 $1.77 Million
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $59,847 - $74,967	-828 Reduced 2.7%	29,841 $2.29 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $125,296 - $137,794	-1,748 Reduced 5.39%	30,669 $2.3 Million
Q2 2021 Jul 27, 2021	SELL	$70.31 - $77.77 $481,131 - $532,180	-6,843 Reduced 17.43%	32,417 $2.52 Million
Q1 2021 May 04, 2021	SELL	$68.86 - $81.11 $221,109 - $260,444	-3,211 Reduced 7.56%	39,260 $3.03 Million
Q4 2020 Feb 04, 2021	SELL	$71.77 - $79.65 $479,925 - $532,619	-6,687 Reduced 13.6%	42,471 $3.47 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $24,149 - $27,373	-330 Reduced 0.67%	49,158 $4.08 Million
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $207,175 - $235,742	2,942 Added 6.32%	49,488 $3.83 Million
Q1 2020 May 06, 2020	SELL	$63.36 - $87.82 $844,715 - $1.17 Million	-13,332 Reduced 22.27%	46,546 $3.58 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $89,837 - $101,371	1,158 Added 1.97%	59,878 $5.45 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $192,558 - $209,895	-2,531 Reduced 4.13%	58,720 $4.94 Million
Q2 2019 Aug 09, 2019	SELL	$69.84 - $81.59 $367,428 - $429,244	-5,261 Reduced 7.91%	61,251 $5.14 Million
Q1 2019 May 07, 2019	SELL	$69.58 - $79.36 $206,443 - $235,461	-2,967 Reduced 4.27%	66,512 $5.53 Million
Q4 2018 Feb 04, 2019	BUY	$65.24 - $75.71 $207,267 - $240,530	3,177 Added 4.79%	69,479 $5.31 Million
Q3 2018 Nov 20, 2018	BUY	$57.69 - $67.84 $280,892 - $330,312	4,869 Added 7.93%	66,302 $4.7 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $66,079 - $77,636	1,300 Added 2.16%	61,433 $3.73 Million
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $813,729 - $945,784	15,968 Added 36.16%	60,133 $3.28 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $389,266 - $464,827	7,541 Added 20.59%	44,165 $2.49 Million
Q3 2017 Nov 07, 2017	SELL	$58.67 - $63.13 $9,504 - $10,227	-162 Reduced 0.44%	36,624 $2.35 Million
Q2 2017 Aug 10, 2017	BUY	N/A	36,786	36,786 $2.36 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Merck & Co., Inc. Transaction History